St. Vincent's Institute of Medical Research, and the Department of Medicine at St. Vincent's Hospital, The University of Melbourne, Fitzroy, Melbourne, VIC, 3065, Australia.
Curr Osteoporos Rep. 2019 Oct;17(5):270-280. doi: 10.1007/s11914-019-00524-y.
We outline the diverse processes contributing to bone mineralization and bone matrix maturation by describing two mouse models with bone strength defects caused by restricted deletion of the receptor tyrosine kinase ligand EphrinB2.
Stage-specific EphrinB2 deletion differs in its effects on skeletal strength. Early-stage deletion in osteoblasts leads to osteoblast apoptosis, delayed initiation of mineralization, and increased bone flexibility. Deletion later in the lineage targeted to osteocytes leads to a brittle bone phenotype and increased osteocyte autophagy. In these latter mice, although mineralization is initiated normally, all processes involved in matrix maturation, including mineral accrual, carbonate substitution, and collagen compaction, progress more rapidly. Osteoblasts and osteocytes control the many processes involved in bone mineralization; defining the contributing signaling activities may lead to new ways to understand and treat human skeletal fragilities.
通过描述两种因受体酪氨酸激酶配体 EphrinB2 受限缺失而导致骨强度缺陷的小鼠模型,我们概述了促成骨矿化和骨基质成熟的多种过程。
成骨细胞中 EphrinB2 的阶段性缺失对骨骼强度的影响不同。早期成骨细胞缺失导致成骨细胞凋亡、矿化启动延迟和骨柔韧性增加。谱系中晚期针对骨细胞的缺失导致骨脆表型和骨细胞自噬增加。在后一种小鼠中,尽管矿化正常启动,但涉及基质成熟的所有过程,包括矿物质积累、碳酸盐替代和胶原压实,进展得更快。成骨细胞和骨细胞控制着骨矿化过程中的许多过程;确定参与的信号活动可能会为理解和治疗人类骨骼脆弱性提供新的方法。